TechSci Healthcare Industry Report

  Increasing funding by government for healthcare sector and growing number of dementia cases to drive United States frontotemporal dementia market According to TechSci Research report,  “ United States  Frontotemporal Dementia Market  By Drug Class Type (Antidepressants (Fluoxetine, Fluvoxamine, Sertraline, Paroxetine, Citalopram, Bupropion, Mitrazepine), Antipsychotics (Olanzepine, Quetiapine, Ziprasidone, Aripiprazole, Risperidone, Paliperidone), By Disease Type (Behavior Variant Frontotemporal Dementia (bvFTD), Primary Progressive Aphasia (PPA), Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy, Others), By End User (Hospitals, Specialty Clinics, Others), By Region, Forecast & Opportunities, 2025 ” , the market is expected to undergo significant growth during the forecast period owing to increasing life expectancy rate in the country and growing geriatric population, which is more prone to neurodegenerative dise...

  Growing healthcare costs  is expected to drive the growth of United States wearable medical devices market According to TechSci Research report,  “ United States Wearable Medical Devices Market  By Type (Vital Signs Monitoring Devices v/s Therapeutic Devices), By Product Type (Activity Monitors/Trackers, Smartwatches, Patches, Smart Clothing), By Purpose (Heart rate, Blood Pressure, Body Temperature, Blood oxygen saturation, Posture, Physical Activities, Hearing Aids, Others), By Site (Handheld, Headband, Strap/Clip/Bracelet, Shoe Sensors, Others), By Application (General Health & Fitness, Remote Patient Monitoring, Home Healthcare), By Price Range (Economy, Medium, Premium), By Distribution Channel (Store-Based v/s Non-Store-Based), By Business Segment (B2B Vs B2C), By Region, Forecast & Opportunities, 2025 ” , the United States wearable medical devices market is expected to grow at an impressive rate during the forecast period on account of the growing pr...

  The growing uptake of biopharmaceuticals is expected to drive United States active pharmaceutical ingredient market through 2026 According to TechSci Research report,  “ United States Active Pharmaceutical Ingredient Market  By Method of Synthesis (Biological v/s. Synthetic), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders, Musculoskeletal, Others), By Form (Tablet, Capsule, Injection, Others), By Molecule Type (Small v/s Large), By Potency (High v/s Low), By Drug Type (Innovator v/s Generic), By Region, Competition Forecast & Opportunities, 2016 – 2026” , the United States active pharmaceutical ingredient market  stood at USD17.81 billion in 2020 and is projected to grow at a CAGR of 9.73% to cross USD31.48 billion by 2026. This can be accredited to the growing geriatric population across the country w...

  Increasing technological innovations in the field of tissue engineering and stem cell therapy is expected to drive the growth of United States regenerative medicine market According to TechSci Research report,  “ United States  Regenerative Medicine Market   By Type (Cell-based immunotherapy & Cell therapy products, Gene therapy products, Tissue-engineered products, Others), By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material, Others), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, Others), By Region, Forecast & Opportunities, 2025 ” , the United States regenerative medicine market is expected to grow at a formidable rate of around 13% during the forecast period on account of the rising prevalence of chronic and genetic disorders, increased healthcare expenditure by the government, growing demand for organ transplantations, among others. Additionally, ...

  Growing adoption of DIY (Do-it-Yourself) testing and diagnostics concept is expected to drive the growth of United States patient at home testing kits market . Acc ording to TechSci report on, “ United States Patient At Home Testing Kits Market  By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others), By Sample (Blood, Urine, Saliva), By Usage (Disposable v/s Reusable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast & Opportunities, 2026 ”,   United States patient at home testing kits market stood at USD3239.54 million and is expected to grow at a CAGR of 7.94% during the forecast period. The growing healthcare awareness among the population about the prevalence, causes, symptoms, diagnosis and treatment of different diseases is expected to fuel the growth of the United States patient at home testing kits market. The po...